Position
Entropy Technologies, LP in Madrigal Pharmaceuticals, Inc.
Back to the book · All holders of MDGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$331.2K$582.34 → $523.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.94K | $4.04M | — | — | — | 0.2% |
| Q1 2026 | 5.63K | $2.95M | $523.47 | −$331.2K | −$766.4K | 0.1% |